Terveystalo Valuation Multiples

Discover Terveystalo's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Clinica Baviera, Thomson Medical, Dr. Sulaiman Al Habib Medical Services, HCG Hospitals and more.

Terveystalo Overview

About Terveystalo

Terveystalo PLC o is a healthcare service provider in Finland. The company offers primary and specialized healthcare services to corporate, private, and public sector customers. Its healthcare service offering includes general practice and specialist medical care, diagnostic services, outpatient surgery, dental services and other adjacent services; it covers the entire integrated treatment chain of healthcare. The Group comprises of three reporting segments: Healthcare Services, Portfolio Businesses, and Sweden, out of which it derives maximum revenue from Healthcare Services segment.


Founded

2001

HQ

Finland

Employees

9.2K

Financials (LTM)

Revenue: $1.5B
EBITDA: $273M

EV

$1.7B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Terveystalo Financials

Terveystalo reported last 12-month revenue of $1.5B and EBITDA of $273M.

In the same LTM period, Terveystalo generated $875M in gross profit, $273M in EBITDA, and $101M in net income.

Revenue (LTM)


Terveystalo P&L

In the most recent fiscal year, Terveystalo reported revenue of $1.5B and EBITDA of $294M.

Terveystalo is profitable as of last fiscal year, with gross margin of 58%, EBITDA margin of 19%, and net margin of 7%.

See analyst estimates for Terveystalo
LTMLast FY202320242025202620272028
Revenue$1.5B$1.5B$1.5B$1.5B$1.5B
Gross Profit$875M$882M$860M$906M$882M
Gross Margin60%58%58%59%60%
EBITDA$273M$294M$104M$249M$267M
EBITDA Margin19%19%7%16%18%
EBIT Margin12%12%6%9%11%
Net Profit$101M$110M($48M)$82M$106M
Net Margin7%7%(3%)5%7%
Net Debt-$351M---

Financial data powered by Morningstar, Inc.

Terveystalo Stock Performance

Terveystalo has current market cap of $1.1B, and enterprise value of $1.7B.

Market Cap Evolution


Terveystalo's stock price is $8.40.

Terveystalo share price decreased by 4.0% in the last 30 days, and by 32.4% in the last year.

Terveystalo has an EPS (earnings per share) of $0.87.

See more trading valuation data for Terveystalo
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.7B$1.1B4.5%-4.0%-7.9%-32.4%$0.87

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Terveystalo Valuation Multiples

Terveystalo trades at 1.2x EV/Revenue multiple, and 6.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Terveystalo

EV / Revenue (LTM)


Terveystalo Financial Valuation Multiples

As of July 17, 2026, Terveystalo has market cap of $1.1B and EV of $1.7B.

Terveystalo has a P/E ratio of 10.5x.

LTMLast FY202320242025202620272028
EV/Revenue1.2x1.1x1.1x1.1x1.1x
EV/EBITDA6.2x5.7x16.1x6.7x6.3x
EV/EBIT9.9x9.1x20.5x12.3x10.4x
EV/Gross Profit1.9x1.9x2.0x1.9x1.9x
P/E10.5x9.7x(22.0x)12.9x10.0x
EV/FCF15.0x9.4x12.5x7.9x9.4x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Terveystalo Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Terveystalo Margins & Growth Rates

Terveystalo decreased revenue by 7% and EBITDA by 13% in the last fiscal year.

In the most recent fiscal year, Terveystalo reported gross margin of 58%, EBITDA margin of 19%, and net margin of 7%.

See estimated margins and future growth rates for Terveystalo

Terveystalo Margins

Last FY202420252026202720282029
Gross Margin58%59%60%60%
EBITDA Margin19%16%18%18%
EBIT Margin12%9%11%11%
Net Margin7%5%7%7%
FCF Margin12%14%12%6%

Terveystalo Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(7%)4%(5%)(4%)
Gross Profit Growth(4%)5%(3%)(4%)
EBITDA Growth(13%)140%7%(4%)
EBIT Growth(16%)67%18%(4%)
Net Profit Growth(14%)(270%)29%(12%)
FCF Growth(49%)57%(16%)(49%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Terveystalo Operational KPIs

Terveystalo's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Terveystalo's Rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Terveystalo's Rule of X is 8% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Terveystalo
LTMLast FY202320242025202620272028
Rule of 4018%14%---
Bessemer Rule of X17%8%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue-1%1%1%1%
R&D Expenses to Revenue0%0%--0%
Opex to Revenue-48%53%50%49%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Clinica Baviera3.1x2.9x10.9x10.3x
Thomson Medical6.1x-41.6x-
Dr. Sulaiman Al Habib Medical Services3.1x-11.3x-
HCG Hospitals4.3x4.2x23.8x22.2x
Rhoen Klinikum0.4x0.4x5.9x5.8x
Nutex Health1.5x1.4x4.4x5.3x
U.S. Physical Therapy1.9x1.8x13.3x14.7x
Spire Healthcare Group1.4x1.4x8.2x8.0x

This data is available for Pro users. Sign up to see all Terveystalo competitors and their valuation data.

Start Free Trial

Acquisitions by Terveystalo

Terveystalo has acquired 11 companies to date.

Last acquisition by Terveystalo was on June 7th 2026. Terveystalo acquired Silmäasema for $668M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Terveystalo

Silmäasema
Hohde Group
Silmäsairaala Pilke
Veikkolan Hammaslääkäriasema
Description
Silmäasema is a Finland-based optical retailer and eye care provider operating 140 stores and 13 clinics across Finland and Estonia. Services encompass prescription eyewear, contact lenses, laser surgeries, and specialist ophthalmology. The network includes in-house labs producing custom lenses and diagnostic centers using OCT imaging. As the second-largest chain in Finland, Silmäasema partners with Essilor and Zeiss for lens technologies and serves over 1 million patients annually.
Hohde Group is a Finnish network of private dental clinics and laboratories delivering comprehensive oral health services nationwide.
Silmäsairaala Pilke is a Finland-based eye hospital providing comprehensive ophthalmology services, examinations, and surgeries for cataracts, lenses, and refractive corrections.
Veikkolan Hammaslääkäriasema is a Kirkkonummi-based dental clinic in Finland offering bite rehabilitation, implants, prosthetics, and surgery. It serves 5,000 patients annually with digital X-rays and CAD/CAM crowns. Established in 2005, the clinic partners with Colosseum Dental for specialized treatments.
HQ CountryFinlandFinlandFinlandFinland
HQ City
Helsinki
-
-
Veikkola
Deal Date7 Jun 202623 Dec 20253 Dec 202524 Apr 2025
Valuation$668M$95Mundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Terveystalo acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Terveystalo

Terveystalo has invested in 1 company to date.

Latest investment by Terveystalo was on November 27th 2025. Terveystalo invested in Gosta Labs in their $9M Seed round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Terveystalo

Gosta Labs
Description
Gosta Labs is a healthcare AI company building specialized machine learning models for clinical workflows. Based in the United States, it develops predictive algorithms for patient triage, readmission risk, and resource allocation, integrating with electronic health records to enhance hospital efficiency.
HQ CountryFinland
HQ City
Espoo
Deal Date27 Nov 2025
RoundSeed
Raised$9M
InvestorsVoima Ventures; Reaktor; Cor Group; The Aho family; Terveystalo
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Terveystalo investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Terveystalo

When was Terveystalo founded?Terveystalo was founded in 2001.
Where is Terveystalo headquartered?Terveystalo is headquartered in Finland.
How many employees does Terveystalo have?As of today, Terveystalo has over 9K employees.
Who is the CEO of Terveystalo?Terveystalo's CEO is Ville Iho.
Is Terveystalo publicly listed?Yes, Terveystalo is a public company listed on Nasdaq Helsinki.
What is the stock symbol of Terveystalo?Terveystalo trades under TTALO ticker.
When did Terveystalo go public?Terveystalo went public in 2017.
Who are competitors of Terveystalo?Terveystalo main competitors include Clinica Baviera, Thomson Medical, Dr. Sulaiman Al Habib Medical Services, HCG Hospitals, Rhoen Klinikum, Nutex Health, U.S. Physical Therapy, Spire Healthcare Group, Al Hammadi Holding, Life Healthcare Group.
What is the current market cap of Terveystalo?Terveystalo's current market cap is $1.1B.
What is the current revenue of Terveystalo?Terveystalo's last 12 months revenue is $1.5B.
What is the current revenue growth of Terveystalo?Terveystalo revenue growth (NTM/LTM) is (1%).
What is the current EV/Revenue multiple of Terveystalo?Current revenue multiple of Terveystalo is 1.2x.
What is the current EBITDA of Terveystalo?Terveystalo's last 12 months EBITDA is $273M.
What is Terveystalo's EBITDA margin?Terveystalo's last 12 months EBITDA margin is 19%.
What is the current EV/EBITDA multiple of Terveystalo?Current EBITDA multiple of Terveystalo is 6.2x.
What is the current FCF of Terveystalo?Terveystalo's last 12 months FCF is $112M.
What is Terveystalo's FCF margin?Terveystalo's last 12 months FCF margin is 8%.
What is the current EV/FCF multiple of Terveystalo?Current FCF multiple of Terveystalo is 15.0x.
How many companies Terveystalo has acquired to date?As of July 2026, Terveystalo has acquired 11 companies.
What was the largest acquisition by Terveystalo?$668M acquisition of Silmäasema on 7th June 2026 was the largest M&A Terveystalo has done to date.
What companies Terveystalo acquired?Terveystalo acquired Silmäasema, Hohde Group, Fysiogeriatria, Suomen Hierojakoulut, Cityläkarna, Silmäsairaala Pilke, Veikkolan Hammaslääkäriasema, Nuorten Sutela, SRK Group, Namndemansgarden, and 1 other company.
In how many companies Terveystalo has invested to date?As of July 2026, Terveystalo has invested in 1 company.
What was the last Terveystalo investment?On 27th November 2025 Terveystalo invested in Gosta Labs, participating in a $9M Seed round, alongside Voima Ventures, Reaktor, Cor Group, and The Aho family.
In what companies Terveystalo invested in?Terveystalo invested in Gosta Labs.

See public comps similar to Terveystalo

Lists including Terveystalo

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial